News|Videos|January 20, 2025
Your Guide to 2025: Pharma, Formularies, the Pipeline and More
Advertisement
This webinar, “Your Guide to 2025: Pharma, Formularies, the Pipeline and More” featured Luke Greenwalt, MBA,vice president and lead of the Market Access Center of Excellence at IQVIA, an Jeff Casberg, RPh, M.S., senior vice president, clinical pharmacy at IPD Analytics. Greenwalt and Casberg, both of whom are on the Managed Healthcare Executive editorial advisory board, discussed the market trends for GLP-1s and biosimilars; the ’25 drug pipeline; and the prospects for PBM legislation.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Older drug could slash blood transfusions during surgeries | ASH 2025
2
Sanofi’s Qfitlia seems favorable for hemophilia with easier dosing and broad coverage | ASH 2025
3
The trend toward post-infusion outpatient care of patients treated with CAR-T | ASH 2025
4
Breakthrough treatments offer hope for melanoma patients
5

















































